Protooncogenes and autoimmunity

M. Rapoport, A. Mor, T. Bistritzer, Y. Ramot, O. Levi, S. Slavin, A. Wysenbeek

Research output: Contribution to journalShort surveypeer-review


A strong linkage, supported by data from animal models and human patients, exists between aberrant overexpression of protooncogenes and autoimmune states. However, overexpression is not always the rule. Some protooncogenes are underexpressed or demonstrate lower activity, e.g. p21ras in insulin-dependent diabetes mellitus, and in the same disease, different protooncogenes may be up- and down-regulated simultaneously. This indicates that the expression and function of different protooncogenes may differ among autoimmune diseases. It also indicates that the role of each protooncogene in the pathogenesis of a particular autoimmune disease should be determined separately.

Original languageEnglish
Pages (from-to)262-266
Number of pages5
JournalIsrael Journal of Medical Sciences
Issue number4
StatePublished - Apr 1997
Externally publishedYes


  • Autoimmunity
  • Protooncogenes
  • p21ras


Dive into the research topics of 'Protooncogenes and autoimmunity'. Together they form a unique fingerprint.

Cite this